GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (LTS:0R6U) » Definitions » Gross-Profit-to-Asset %

4SC AG (LTS:0R6U) Gross-Profit-to-Asset % : 3.23% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is 4SC AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. 4SC AG's annualized Gross Profit for the quarter that ended in Dec. 2023 was €0.37 Mil. 4SC AG's average Total Assets over the quarter that ended in Dec. 2023 was €11.38 Mil. Therefore, 4SC AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 3.23%.


4SC AG Gross-Profit-to-Asset % Historical Data

The historical data trend for 4SC AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG Gross-Profit-to-Asset % Chart

4SC AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.40 3.63 36.42 1.14 1.62

4SC AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.38 2.55 0.34 3.23

Competitive Comparison of 4SC AG's Gross-Profit-to-Asset %

For the Biotechnology subindustry, 4SC AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4SC AG's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4SC AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where 4SC AG's Gross-Profit-to-Asset % falls into.



4SC AG Gross-Profit-to-Asset % Calculation

4SC AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.209/( (16.401+9.403)/ 2 )
=0.209/12.902
=1.62 %

4SC AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.368/( (13.365+9.403)/ 2 )
=0.368/11.384
=3.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


4SC AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of 4SC AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


4SC AG (LTS:0R6U) Business Description

Industry
Traded in Other Exchanges
Address
Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG (LTS:0R6U) Headlines

No Headlines